The long-term prognosis of tension-type headache

Current Pain and Headache Reports

Volumn 9, Issue 6, 2005, Pages 436-441

  Couch, James R ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIMIGRAINE AGENT; BENZODIAZEPINE DERIVATIVE; ERGOTAMINE DERIVATIVE; MUSCLE RELAXANT AGENT; NARCOTIC ANALGESIC AGENT; SUMATRIPTAN;

AGE; CHRONIC TENSION HEADACHE; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG USE; DRUG WITHDRAWAL; EPISODIC TENSION HEADACHE; HEALTH SURVEY; HUMAN; INCIDENCE; MIGRAINE; MORBIDITY; PREVALENCE; PROGNOSIS; REVIEW; TENSION HEADACHE;

EID: 28944446565     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-005-0024-5     Document Type: Review

References (32)

1. Headache Classification Committee of the International Headache Society: The International Classification of Headache Disorders. Cephalalgia 2004, 24(suppl 1):1-160.
2. Headache Classification Committee of the International Headache Society: The International Classification of Headache Disorders. Cephalalgia 1988, 8(suppl 7):1-96.
3. Silberstein SD, Lipton RB, Sliwinski M: Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996, 47:871-875.
4. Critchley M: Migraine: from Cappadocia to Queen Square. In Background to Migraine, vol 1. Edited by Smith R. London: Heinemann; 1967.
5. Bigal ME, Sheftell FD, Tepper SJ, et al.: Migraine days decline with duration of illness in adolescents with transformed migraine. Cephalalgia 2005, 25:482-487.
6. Spierings EL, Ranke AH, Schroevers M, Honkoop PC: Chronic daily headache: a time perspective. Headache 2000, 40:306-310.
7. Ziegler DK, Hassanein RS, Couch JR: Headache syndromes suggested by statistical analysis of headache symptoms. Cephalalgia 1982, 2:125-134.
8. Lipton RB, Stewart WF, Cady R, et al.: Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache 2000, 40:783-791.
9. Diener HC, Limmroth V: Medication-overuse headache: a worldwide problem. Lancet Neurol 2004, 3:475-483.
10. Diener HC, Dahlöf CG: Headache associated with chronic use of substances. In The Headaches, edn 2. Edited by Olesen J, Tfelt-Hansen P, Welch KM. Philadelphia: Lippincott Williams & Wilkins; 2000:871-877.
11. Peters GA, Horton BT: Headache with special reference to the excessive use of ergotamine tartrate and dihydroergotamine. J Lab Clin Med 1950, 36:972.
12. Friedman AP, Brazil PL, Von Storch TJ: Ergotamine tolerance in patients with migraine. JAMA 1955, 157:881-884.
13. Horton BT, Peters GA: Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache 1963, 2:214-227.
14. Young WB: Clinical science: treatment of medication-overuse headache and long-term outcome. Headache Currents 2004, 1:55-59.
15. Couch JR: Chronic daily headache. Curr Treat Options Neurol 2003, 5:467-479.
16. Stewart WF, Lipton RB, Dowson AJ, Sawyer J: Development and testing of Migraine Disability Assessment (MIDAS) questionnaire to assess headache-related disability. Neurology 2001, 56(suppl 1):S20-S28.
17. Jakubowski M, Levy D, Goor-Aryeh I, et al.: Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache 2005, 45:850-861.
18. Andersson PG: Ergotamine headache. Headache 1975, 15:118-121.
19. Tfelt-Hansen F, Krabbe A: Ergotamine abuse: Do patients benefit from withdrawal? Cephalalgia 1981, 1:29-32.
20. Katsarava Z, Diener HC, Limmroth V: Medication-overuse headache: a focus on analgesics, ergot alkaloids, and triptans. Drug Safety 2001, 24:921-927.
21. Baumgartner C, Wessely P, Bingöl C, et al.: Long-term prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 1989, 29:510-514.
22. Diener HC, Dichgans J, Scholz E, et al.: Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 1989, 236:9-14.
23. Schnider P, Aull S, Baumgartner C, et al.: Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: 5-year follow-up. Cephalalgia 1996, 16:481-485.
24. Pini LA, Cicero AF, Sandrini M: Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia 2001, 21:878-883.
25. Katsarava Z, Limmroth V, Finke M, et al.: Rates and predictors for relapse in medication-overuse headache: a 1-year prospective study. Neurology 2003, 60:1682-1683.
26. Schwartz BS, Stewart WF, Simon D, Lipton RB: Epidemiology of tension-type headache. J Am Med Assoc 1998, 279:381-383.
27. Rasmussen B, Jensen R, Schroll M, et al.: Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 1991, 44:1147-1157.
28. Göbel H, Petersen-Braun M, Soyka D: The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia 1994, 14:97-106.
29. Wang SJ, Liu HC, Fuh JL, et al.: Prevalence of headaches in a Chinese elderly population in Kinmen: age and gender effect and cross-cultural comparisons. Neurology 1997, 49:195-200.
30. Pryse-Phillips W, Findlay H, Tugwell F, et al.: A Canadian population survey on the clinical, epidemiologic, and societal impact of migraine and tension-type headache. Can J Neurol Sci 1992, 19:333-339.
31. Roh JK, Kim JS, Ahn YO: Epidemiologic and clinical characteristics of migraine and tension-type headache in Korea. Headache 1998, 38:356-365.
32. Lavados PM, Tenhamm E: Epidemiology of tension-type headache in Santiago, Chile: a prevalence study. Cephalalgia 1998, 18:552-558.